Rabbit IgG anti-Sheep IgG (F(ab)2)-FITC, MinX none

Catalog Number: DNA-SEC-182621
Article Name: Rabbit IgG anti-Sheep IgG (F(ab)2)-FITC, MinX none
Biozol Catalog Number: DNA-SEC-182621
Supplier Catalog Number: SEC-182621
Alternative Catalog Number: DNA-SEC-182621
Manufacturer: dianova
Host: Rabbit
Category: Antikörper
Application: FLISA,FACS,IF
Species Reactivity: Sheep
Immunogen: Sheep IgG F(ab)2 fragment
Conjugation: FITC
Alternative Names: rabbit anti-Sheep IgG F(ab)2 Antibody Fluorescein Conjugated, rabbit anti-Sheep IgG F(ab)2 FITC Conjugated Antibody
Format: IgG
Target Specificity: IgG (F(ab')2)
Cross-Adsorption (MinX): no cross-adsorbtion
Anti-Sheep IgG F(ab)2 Fluorescein Antibody generated in rabbit recognizes the dimeric Fab portion of the sheep IgG molecule. Sheep IgG F(ab)2 is a proteolytic fragment of immunoglobulin G (IgG) obtained by limited digestion with the enzyme pepsin under c
Clonality: Polyclonal
Concentration: 10.0 mg/mL
Isotype: Ig
Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Purity: This product is an IgG fraction antibody purified from monospecific antiserum by a multi-step process which includes delipidation, salt fractionation and ion exchange chromatography followed by extensive dialysis against the buffer stated above.  Assay by immunoelectrophoresis resulted in a single precipitin arc against anti-fluorescein, anti-Rabbit Serum, Sheep IgG, Sheep IgG F(ab’)2 and Sheep Serum.  No reaction was noted against Sheep IgG F(c).
Form: Lyophilized
Formula: 20 mM K3PO4,150 mM NaCl,pH 7,2,lyophilisate,0,01% NaN3
Target: Sheep
Antibody Type: Secondary Antibody
Application Dilute: FLISA Dilution: 1:10,000 - 1:50,000, Flow Cytometry Dilution: 1:500 - 1:2,500, Fluorochrome Protein Value: 3.7, IF Microscopy Dilution: 1:1,000 - 1:5,000
Application Notes: This product is designed for immunofluorescence microscopy, fluorescence based plate assays (FLISA) and fluorescent western blotting. This product is also suitable for multiplex analysis, including multicolor imaging, utilizing various commercial platforms.